Clinical Trial Update: Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from Washington State University evaluating pharmaceutically-enhanced reinforcement to reduce alcohol and nicotine use disorders. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Nicotine Use Disorder

Snippet

Sponsor: Washington State University | Conditions: Alcohol Use Disorder (AUD), Nicotine Use Disorder | Phase 2 | Status: RECRUITING